Lymphoma
📧 Sign up to get email alerts when something new happens for Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2021-08-13Clinical Trial Update: Combination Chemotherapy and Donor Stem Cell Transplant in Treating Patients With Aplastic Anemia or Hematologic Cancer [Phase 2, Phase 3]
Phase 2/Phase 3 trial evaluating combination chemotherapy with donor stem cell transplant for aplastic anemia and hematologic cancers; compl…
-
CLINICAL_TRIALS trial_result · 2021-08-11Clinical Trial Update: Clinical Study the Efficacy and Safety of Rh-EPO in the Treatment of Anemia in Lymphoma [Phase 3]
A Phase 3 clinical trial evaluating the efficacy and safety of recombinant human erythropoietin (Rh-EPO) for anemia associated with lymphoma…
-
CLINICAL_TRIALS trial_result · 2021-08-10Clinical Trial Update: Testing AZD5363 as a Potential Targeted Treatment in Cancers With AKT Genetic Changes (MATCH-Subprotocol Y) [Phase 2]
A Phase 2 MATCH subprotocol evaluating AZD5363 (capivasertib) for cancers with AKT genetic alterations; the study is marked as active but no…
-
CLINICAL_TRIALS trial_result · 2021-07-28Clinical Trial Update: A Phase I Study of Zalypsis (PM00104) in Subjects With Advanced Malignant Solid Tumors or Lymphoma [Phase 1]
Phase I study of Zalypsis (PM00104) in advanced malignant solid tumors or lymphoma; the trial status is terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2021-06-29Clinical Trial Update: Testing AZD4547 as a Potential Targeted Treatment in Cancers With FGFR Genetic Changes (MATCH-Subprotocol W) [Phase 2]
Phase 2 MATCH-Subprotocol W trial evaluating AZD4547 for cancers with FGFR genetic alterations has completed with posted results.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2021-06-18Clinical Trial Update: Yttrium Y 90 Ibritumomab Tiuxetan, Etoposide, Cyclophosphamide, and an AHSCT in Non-Hodgkin's Lymphoma Patients [Phase 1, Phase 2]
Phase 1/2 trial investigating a conditioning regimen including Yttrium-90 ibritumomab tiuxetan, etoposide, cyclophosphamide, and autologous …
-
CLINICAL_TRIALS trial_result · 2021-05-18Clinical Trial Update: Rituximab and Combination Chemotherapy in Treating Older Patients With Previously Untreated B-Cell Lymphoma [Phase 2]
Phase 2 clinical trial update investigating rituximab with combination chemotherapy in older patients with previously untreated B-cell lymph…
-
CLINICAL_TRIALS trial_result · 2021-05-07Clinical Trial Update: Study of CAR-20/19-T Cells in Patients With Relapsed Refractory B Cell [Phase 1]
Phase 1 study updating on CAR-20/19-T cells in relapsed/refractory B-cell lymphomas; results posted after completion.
-
CLINICAL_TRIALS trial_result · 2021-05-06Clinical Trial Update: Prevention of Graft-Versus-Host Disease in Patients With Advanced Leukemia or Lymphoma Who Are Eligible for Peripheral Stem Cell Transplantation [Phase 3]
Phase 3 trial update on prevention of graft-versus-host disease in patients with advanced leukemia or lymphoma undergoing peripheral stem ce…
-
CLINICAL_TRIALS trial_result · 2021-05-05Clinical Trial Update: An Open-label, Phase I/II Study of Manganese Plus Radiotherapy in Patients With Metastatic Solid Tumors or Lymphoma [Phase 1, Phase 2]
Open-label Phase I/II study investigating manganese plus radiotherapy in patients with metastatic solid tumors or lymphoma; current status a…
-
CLINICAL_TRIALS trial_result · 2021-04-28Clinical Trial Update: Relevance of a Web-mediated Follow up in Patients Having a Lymphoma With a High Risk of Relapse in Complete or Partial Response [NA]
Clinical trial update for a web-mediated follow-up in lymphoma patients at high risk of relapse; the study has terminated with posted result…
-
CLINICAL_TRIALS trial_result · 2021-04-06Clinical Trial Update: Testing Nivolumab as a Potential Targeted Treatment in Cancers With Mismatch Repair Deficiency (MATCH-Subprotocol Z1D) [Phase 2]
Phase 2 trial evaluating nivolumab in cancers with mismatch repair deficiency has completed; results were posted in 2021.
-
CLINICAL_TRIALS trial_result · 2021-03-19Clinical Trial Update: Anti-CD19 Chimeric Antigen Receptor (CAR)-Transduced T Cell Therapy for Patients With B Cell Malignancies [Phase 1, Phase 2]
A Phase 1/2 clinical trial update for an anti-CD19 CAR-T cell therapy in B cell malignancies has completed recruiting.
-
CLINICAL_TRIALS trial_result · 2021-03-15Clinical Trial Update: Avatrombopag for the Primary Prevention of Thrombocytopenia Induced by Cytarabine-based Chemotherapy in Patients With Lymphoma [Phase 2]
Phase 2 clinical trial evaluating avatrombopag for primary prevention of cytarabine-induced thrombocytopenia in lymphoma patients.
-
CLINICAL_TRIALS trial_result · 2021-03-11Clinical Trial Update: 18F- Fluorothymidine to Evaluate Treatment Response in Lymphoma [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating 18F-Fluorothymidine to assess treatment response in lymphoma has terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2021-03-03Clinical Trial Update: Testing Trametinib as a Potential Targeted Treatment in Cancers With BRAF Genetic Changes (MATCH-Subprotocol R) [Phase 2]
The National Cancer Institute’s MATCH subprotocol R Phase 2 trial is evaluating trametinib as a targeted therapy for cancers with BRAF genet…
-
CLINICAL_TRIALS trial_result · 2021-02-21Clinical Trial Update: Combination Chemotherapy in Treating Children With Non-Hodgkin's Lymphoma [Phase 3]
A phase 3 clinical trial update evaluating combination chemotherapy in treating children with lymphomas has been completed.
-
CLINICAL_TRIALS trial_result · 2021-02-21Clinical Trial Update: Ridaforolimus and Vorinostat in Treating Patients With Advanced Solid Tumors or Lymphoma [Phase 1]
Phase 1 trial of ridaforolimus and vorinostat in advanced solid tumors or lymphoma completed; results posted.
-
CLINICAL_TRIALS trial_result · 2021-02-21Clinical Trial Update: Open Label Extension Study of Conatumumab and Ganitumab (AMG 479) [Phase 2]
Open-label extension study of Conatumumab and Ganitumab (AMG 479) in a Phase 2 trial for advanced solid tumors; completed with results poste…
-
CLINICAL_TRIALS trial_result · 2021-02-18Clinical Trial Update: Sym022 (Anti-LAG-3) in Patients With Advanced Solid Tumor Malignancies or Lymphomas [Phase 1]
Phase 1 trial update for Sym022 (anti-LAG-3) in patients with advanced solid tumors or lymphomas has finished enrollment with results posted…
-
CLINICAL_TRIALS trial_result · 2021-02-09Clinical Trial Update: Anti-CD22 CAR-T Cell Therapy Targeting B Cell Malignancies [Phase 1, Phase 2]
Phase 1/2 clinical trial update for an anti-CD22 CAR-T cell therapy targeting leukemia and lymphoma.
-
CLINICAL_TRIALS trial_result · 2021-02-05Clinical Trial Update: Testing Ado-Trastuzumab Emtansine as a Potential Targeted Treatment in Cancers With HER2 Genetic Changes (MATCH-Subprotocol Q) [Phase 2]
A Phase 2 MATCH-subprotocol Q trial evaluating ado-trastuzumab emtansine (T-DM1) for cancers with HER2 genetic changes; results were posted …
-
CLINICAL_TRIALS trial_result · 2021-02-02Clinical Trial Update: Zevalin/BEAM/Rituximab vs BEAM/Rituximab With or Without Rituximab in Autologous Stem Cell Transplantation [Phase 2]
Phase 2 trial comparing Zevalin/BEAM/Rituximab versus BEAM/Rituximab with or without Rituximab as conditioning for autologous stem cell tran…
-
CLINICAL_TRIALS trial_result · 2021-01-22Clinical Trial Update: Dalteparin in Preventing DVT in Participants With Cancer [NA]
Clinical trial update for dalteparin in preventing DVT in cancer patients; study completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-01-14Clinical Trial Update: A Study to Assess the Clinical Efficacy and Safety of Daratumumab in Participants With Relapsed or Refractory Natural Killer/T-Cell Lymphoma (NKTCL), Nasal Type [Phase 2]
Phase 2 clinical trial assessing daratumumab for relapsed or refractory natural killer/T-cell lymphoma, nasal type; study completed with pos…